Tridot Test: What This HIV Rapid Test Is and How It Works

A Tridot test is a rapid immunochromatographic assay that detects antibodies to HIV-1 and HIV-2 in a blood sample. It does not detect the virus itself. When a person is infected with HIV, the immune system responds by producing antibodies against the virus.

The Tridot test identifies whether those antibodies are present in the blood at the time of testing.

This distinction between antibody detection and virus detection is clinically important. It determines when the test is most informative, what a negative result actually means, and why timing relative to potential exposure affects result reliability.

The test is designed exclusively for in vitro diagnostic use and functions as a screening tool. A reactive result from a Tridot test triggers confirmatory testing using a more specific laboratory method before any clinical conclusion is reached.

A Tridot test is used as a first-line HIV screening tool because it produces results within minutes without requiring a full laboratory setup for processing. Common clinical indications include:

Routine sexual health screening in individuals who are sexually active or who have had new partners. Post-exposure testing following unprotected sexual contact, needle-sharing, or accidental blood contact.

Investigation of symptoms including unexplained prolonged fever, significant unexplained weight loss, swollen lymph nodes, or recurrent opportunistic infections. Pre-marital, life insurance, or employment health assessments where HIV screening is required.

Antenatal screening, where early identification of HIV infection allows intervention to reduce mother-to-child transmission.

Sample collection

The test requires a small blood sample collected either through a finger-prick or a standard venous draw, depending on the facility's protocol.

No fasting is required and no preparation beyond removing clothing or jewellery near the collection site. A brief clinical history including current medications is typically recorded before collection.

Laboratory processing and result reading

The sample is applied to the Tridot device in a defined sequence: buffer solution is added first, followed by the blood sample, then a protein-A conjugate. Each addition is separated by a brief absorption interval.

Results are visible within approximately three minutes, though clinical protocols typically allow up to 20 minutes to ensure the result is complete and legible before it is recorded.

The device produces three visible dots. The first is a control dot confirming the assay ran correctly. The second and third are reactive dots corresponding to HIV-1 and HIV-2, respectively. The pattern of dots that appear determines the result category.

A large comparative evaluation covering more than 23,000 serum samples benchmarked the Tridot test against fourth-generation ELISA. Sensitivity was recorded at 99.48 per cent and specificity at 99.99 percent. These figures represent the test's ability to correctly identify infected individuals and correctly exclude uninfected ones, respectively.

National AIDS Control Organisation guidelines for rapid HIV testing in India specify that rapid test kits used at integrated counselling and testing centres must detect more than 99.5 per cent of HIV-infected individuals while maintaining a false-positive rate below 2 per cent.

Despite high accuracy figures, a reactive result from a rapid test is never used as a standalone diagnostic conclusion. The confirmation requirement exists because even a very low false-positive rate produces incorrect results at a population screening scale, and the clinical and social consequences of a false HIV diagnosis are significant.

A reactive or positive result means that HIV antibodies were detected in the sample. This indicates a likely HIV infection but is not a confirmed diagnosis. A separate confirmatory test, typically a Western blot or a second-line ELISA using a different antigen configuration, is conducted before any clinical or administrative conclusion is reached.

A negative result means no HIV antibodies were detected at the time of testing. The reliability of a negative result depends entirely on when the test was taken relative to any potential exposure. Testing within the window period can produce a negative result in a person who is infected but has not yet produced detectable antibody levels.

The window period is the interval between HIV infection and the point at which antibody levels in the blood reach a concentration detectable by current testing methods.

For standard antibody-based tests, including the Tridot, this period is generally six to twelve weeks, though in some individuals it extends to six months.

A negative result obtained during the window period does not exclude infection. Clinical guidance is to repeat testing after the window period has passed when any potential exposure has occurred, particularly when the exposure was recent or carried significant transmission risk.

This is not a limitation specific to the Tridot test. It applies to all antibody-based HIV screening methods. Fourth-generation combination antigen and antibody tests reduce but do not eliminate the window period by detecting the p24 antigen, which appears in the blood earlier than antibodies.

Where concern about recent infection is the specific clinical question, the treating clinician will select the most appropriate test format.

HIV testing occupies a category where access barriers, specifically concerns about confidentiality, hesitation about the procedure, and uncertainty about result interpretation, contribute to testing avoidance. The clinical and public health consequences of untested HIV infection are substantially worse than any discomfort involved in the testing process itself.

Diagnostics: 8,500+ NABL-Accredited Labs: Employees can book a Tridot test cashlessly through Visit Health's diagnostic network across India. Every facility in the network is NABL-accredited. Home sample collection is available, and results are accessible through the app with full confidentiality maintained at every stage.

Teleconsultation: Internal Medicine and Infectious Disease: A reactive Tridot result requires immediate clinical guidance on confirmatory testing, next steps, and support resources. Visit Health's teleconsultation platform connects employees with internal medicine and infectious disease specialists across 30 or more specialities, same day, without a hospital visit or a separate referral chain.

AI-Powered Smart Reports: Tridot results and the confirmatory test reports that follow require clinical interpretation to understand what they mean in the context of the individual's exposure history and window period.

Visit Health's smart reports provide plain-language explanations of what each result indicates and what the recommended next step is.

Visit Clinic: For employees in Bengaluru who prefer an in-person consultation for HIV testing, counselling, or follow-up, Visit Clinic provides on-ground appointments with the same confidentiality standards as the teleconsultation platform.

The Tridot test provides rapid, accurate HIV screening that is accessible outside full laboratory settings. Its clinical value depends on two factors that many people do not consider before testing: whether enough time has passed since potential exposure for antibodies to reach detectable levels and whether a reactive result will be followed through to confirmatory testing rather than treated.

What does a Tridot test check for? 

Antibodies to HIV-1 and HIV-2 in a blood sample. It does not detect the virus itself.

How is the Tridot test different from ELISA? 

The Tridot test is a rapid visual immunoassay producing a result in 15 to 20 minutes. ELISA is a laboratory-based method requiring longer processing and is used as a confirmatory test when a rapid test produces a reactive result.

Is the Tridot test painful?

 No. It requires a finger-prick or standard venous blood draw, no different from any routine blood test. No fasting or preparation is required.

How accurate is the Tridot test? 

Clinical studies report sensitivity of approximately 99.5 per cent and a specificity of 99.9 to 99.99 per cent against fourth-generation ELISA. A reactive result still requires confirmatory testing before a diagnosis is finalised.

What does a positive Tridot result mean? 

That HIV antibodies were detected, indicating likely infection. It is not a confirmed diagnosis. A separate confirmatory test is conducted before any clinical conclusion is reached.

What does a negative Tridot result mean? 

That no HIV antibodies were detected at the time of testing. This is reliably informative only if the window period since any potential exposure has passed.

How soon after exposure should the test be taken? 

Testing is often conducted immediately after a potential exposure and repeated after the window period, typically six to twelve weeks. A single negative result within the window

period does not exclude infection.

Is the Tridot test confidential? 

Yes. HIV testing through accredited laboratories and the Visit Health platform is managed with strict confidentiality at every stage, from sample collection to result delivery.

Get your Tridot results explained confidentially by a specialist the same day. Book a cashless test or consult in person at Visit Clinic.